Cognitive and brain imaging measures of Alzheimer's disease.
Diagnosis of Alzheimer's disease (AD) during life relies upon clinical and neurobehavioral symptoms but is presumptive without microscopic verification of neuropathology. Studies in this review observed considerable heterogeneity in AD symptoms and did not agree on how to detect the earliest symptoms. Problems exist in diagnosis. Differences in symptoms and diagnosis result from how AD is defined neurobehaviorally and on the model used for description. The studies reviewed have been considered under three basic models: A severity (staging) model; a heterogeneity (subtyping) model; and an information processing model. Differences in model intent have resulted in differences in disease description. Brain imaging measures have not invalidated models but add the neural substrate needed to examine correlation of measures within each model.
Riege
W H
WH
Sepulveda VA Medical Center, CA 91343.
Metter
E J
EJ
D000368:Aged; D000544:Alzheimer Disease / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000523:psychology*; D001921:Brain / Q000000981:diagnostic imaging*; D003071:Cognition / Q000502:physiology*; D003704:Dementia / Q000175:diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D008568:Memory / Q000502:physiology; D012720:Severity of Illness Index; D014055:Tomography, Emission-Computed